Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Human Glucosylceramidase Protein, His Tag

Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose. Thereby, it plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, it participates in the PKC-activated salvage pathway of ceramide formation and plays a role in cholesterol metabolism. It may either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol. Defects in Glucosylceramidase are the cause of Gaucher disease, also known as glucocerebrosidase deficiency. Gaucher disease is the most prevalent lysosomal storage disease, characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Currently, enzyme replacement therapy is used to treat patients with the disease.

Product Specifications

Background

Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose. Thereby, it plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, it participates in the PKC-activated salvage pathway of ceramide formation and plays a role in cholesterol metabolism. It may either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol. Defects in Glucosylceramidase are the cause of Gaucher disease, also known as glucocerebrosidase deficiency. Gaucher disease is the most prevalent lysosomal storage disease, characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Currently, enzyme replacement therapy is used to treat patients with the disease.

Specifications

This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 57.5 kDa. The protein migrates as 60-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Accession Number

P04062-1

Expression Region

Ala 40 - Gln 536

Host

HEK293

Target

Glucosylceramidase

Conjugation

Unconjugated

Tag

C-10xHis

Source

Human

Stability

The product MUST be stored at -70°C or lower upon receipt; -70°C for 3 months under sterile conditions.

Endotoxin

1.0 EU per μg

Purity

90%

Format

Liquid

Buffer

0.1 M Sodium citrate, pH5.5

Additives

Glycerol

Molecular Weight

57.5 kDa

Additionnal Information

Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments

Shipping Conditions

Dry ice

Storage Conditions

-70°C

Package Size

20ug*1

Host or Source

HEK293

Species

Human

Protein ID

P04062-1

Preservative

Glycerol

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SAPS2 (PPP6R2) (NM_014678) Human 3' UTR Clone
SC210338 10 µg

SAPS2 (PPP6R2) (NM_014678) Human 3' UTR Clone

Ask
View Details
Cofilin, phosphorylated (Ser3) (FITC)
C7506-20-FITC 100 µL

Cofilin, phosphorylated (Ser3) (FITC)

Ask
View Details
TBCA (NM_001297740) Human Tagged ORF Clone
RG235500 10 µg

TBCA (NM_001297740) Human Tagged ORF Clone

Ask
View Details
LARS2 (KIAA0028, Probable Leucine-tRNA Ligase, Mitochondrial, Leucyl-tRNA Synthetase) (MaxLight 550)
MBS6212274-01 0.1 mL

LARS2 (KIAA0028, Probable Leucine-tRNA Ligase, Mitochondrial, Leucyl-tRNA Synthetase) (MaxLight 550)

Ask
View Details
LARS2 (KIAA0028, Probable Leucine-tRNA Ligase, Mitochondrial, Leucyl-tRNA Synthetase) (MaxLight 550)
MBS6212274-02 5x 0.1 mL

LARS2 (KIAA0028, Probable Leucine-tRNA Ligase, Mitochondrial, Leucyl-tRNA Synthetase) (MaxLight 550)

Ask
View Details
Anti-UCN2 Polyclonal Antibody
PHJ42401 100 μg

Anti-UCN2 Polyclonal Antibody

Ask
View Details